Shopping Cart
- Remove All
Your shopping cart is currently empty
FGFR-IN-7 (compound 17) is an orally active, potent FGFR modulator that penetrates the blood-brain barrier, exhibits neuroprotective properties, enhances brain exposure, and decreases the likelihood of phospholidosis, proving valuable for research on neurodegenerative diseases [1].

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $1,520 | 6-8 weeks | |
| 50 mg | $1,980 | 6-8 weeks | |
| 100 mg | $2,500 | 6-8 weeks |
| Description | FGFR-IN-7 (compound 17) is an orally active, potent FGFR modulator that penetrates the blood-brain barrier, exhibits neuroprotective properties, enhances brain exposure, and decreases the likelihood of phospholidosis, proving valuable for research on neurodegenerative diseases [1]. |
| In vivo | FGFR-IN-7 (compound 17), administered orally at a dosage of 1 mg/kg once daily for a duration of 10 days, significantly improves the recovery of coordinated movement in rats within an acute stroke model in vivo [1]. |
| Molecular Weight | 374.81 |
| Formula | C16H21ClF2N4O2 |
| Cas No. | 2488764-17-4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.